Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
32,548,782
-
Share change
-
+591,504
-
Total reported value
-
$255,197,401
-
Price per share
-
$7.84
-
Number of holders
-
88
-
Value change
-
+$4,747,891
-
Number of buys
-
41
-
Number of sells
-
31
Institutional Holders of MAGENTA THERAPEUTICS INC - COM (MGTA) as of Q4 2020
As of 31 Dec 2020,
MAGENTA THERAPEUTICS INC - COM (MGTA) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,548,782 shares.
The largest 10 holders included
TRV GP IV, LLC, GILDER GAGNON HOWE & CO LLC, Casdin Capital, LLC, Alphabet Inc., Aquilo Capital Management, LLC, BlackRock Inc., VANGUARD GROUP INC, EVENTIDE ASSET MANAGEMENT, LLC, UBS ASSET MANAGEMENT AMERICAS INC, and Bleichroeder LP.
This page lists
88
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.